| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. To extinguish fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. | |
| [Ingestion] Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. | |
| [Inhalation] Remove from exposure to fresh air immediately. | |
| [Skin] Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. | |
| [Storage] Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances. Refrigerator (approx 4 C). Store protected from moisture. | |
| [Handling] Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. | |
| [Skin] Bacitracin has been reported to have a low sensitizing potential but has still caused allergic contact dermatitis, eczema, and histamine wheal and flare. | |
| [Personal Protection] Eyes: Wear safety glasses and chemical goggles if splashing is possible. Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves and clothing to prevent skin exposure. Clothing: Wear appropriate protective gloves and clothing to prevent skin exposure. | |
| [Respirators] Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions. | |
| [Exposure Effects] With therapeutic use - pain at the injection site was a frequent complaint in patients given the drug IM. | |
| [Appearance] White to pale buff powder. Odorless. Hygroscopic. A complex combination of polypeptides produced by the metabolic processes of Bacillus subtilis and licheniformis. | |
| [Solubility in water] Freely soluble | |
| [Melting Point] 221 to 225 | |
| [Usage] Medication: antibacterial. | |
| [Product Name] Bacitracin | |
| [Synonyms] 4-[[2-[[2-(1-Amino-2-methyl-butyl)4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methyl-pentanoyl]amino]-4-[[1-[[18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-3-(carbamoylmethyl)-6-(carboxymethyl)-9-(4H-imidazol-4-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]carbamoyl]-2-methyl-butyl]carbamoyl]butanoic acid zinc Ayfivin Baciguent Baci-Jel Baciliquin Bacitek ointment | |
| [CAS] "CASEN_1405-87-4.htm">1405-87-4 | |
| [Formula] C66H103N17O16S | |
| [Molecular Weight] 1422.71 | |
| [EINECS] 215-786-2 | |
| [RTECS] CP0175000 | |
| [RTECS Class] Drug; Mutagen | |
| [Beilstein/Gmelin] NA | |
| [Small spills/leaks] Clean up spills immediately, using the appropriate protective equipment. Sweep up, then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation. | |
| [Stability] Stable under normal temperatures and pressures. | |
| [Incompatibilities] Strong oxidizing agents, moisture. | |
| [Decomposition] Nitrogen oxides, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide. |
Print